Press releases

Forty-two clinical presentations will provide new insights about Boston Scientific research in cardiovascular disease, including atrial fibrillation and sudden cardiac arrest.

"We continue to be encouraged but not satisfied with our operating performance," said CEO Mike Mahoney.

Earth Week celebration focuses on 3,900-panel project at the company’s international distribution center in Quincy.

Innovative device quickly anchors leads and catheters.

SAMURAI study designed to confirm the safety and effectiveness of ImageReady™ MR Conditional pacing system in the magnetic resonance imaging (MRI) environment.

World's first and only system with Illumina 3D™ software and 32 contacts is designed to provide pain relief to a broad spectrum of chronic pain patients.

Boston Scientific will webcast its conference call with financial results and business highlights for Q1 ended March 31, 2013. Learn how to tune in.

Results Revealed at CIT 2013

Deadly but preventable cancer is a focus during colorectal cancer awareness month

Separate study demonstrates PROMUS Element stent has significantly less vessel straightening than the Xience V® stent.

WATCHMAN® device continues to demonstrate positive clinical outcomes for patients with atrial fibrillation.

Preliminary data in PREVAIL clinical trial met two out of three co-primary endpoints.

First presentation of the preliminary results of all three co-primary endpoints to be revealed during American College of Cardiology 2013 Annual Scientific Sessions.

New tool available to assist in the treatment of peripheral arterial disease.

Clinical presentations will provide new insights on Boston Scientific research in cardiovascular disease, including aortic valve disease and atrial fibrillation.

Boston Scientific will participate in the healthcare conference on February 26 in New York. Learn how to watch the webcast or replay.

Extensive sales resources, distribution network and service capabilities are expected to enable Boston Scientific to reach substantially more accounts, customers and patients in Japan.

Boston Scientific will participate in the healthcare conference on February 25 in New York. Learn how to watch the webcast or replay.

The next advance in durable polymer stent technology from Boston Scientific is now available in Europe and other select geographies.

Boston Scientific will participate in the healthcare conference on February 13 in New York. Learn how to watch the webcast or replay.

Organizations team up to raise awareness and make a call to action for European governments to develop comprehensive chronic pain treatment programs.

“I am confident we are taking the critical steps that are needed to return our company to long-term growth,” said president and CEO Mike Mahoney.

Boston Scientific will webcast its conference call with financial results and business highlights for Q4 and FY ended December 31. Learn how to tune in.

International, multi-center study focuses on patients with paroxysmal atrial fibrillation.

Learn how to tune in or watch the Investor Day replay.